Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from DaVita

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?

The good times keep rolling for Novo Nordisk and its weight-loss drugs. But it's bad news for some medical device stocks.

Investors Business Daily

Why DaVita returned $250 million to the government during the COVID-19 pandemic

CEO Javier Rodriguez says it would have been like accepting food stamps when you have a stocked pantry.

Fortune

DaVita Stock Sees Rising Relative Strength

A Relative Strength Rating upgrade for DaVita shows improving technical performance.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks Under Pressure from U.S. Debt Ceiling Impasse and Weak Chinese Imports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.44%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.56%. U.S. stocks this morning are moderately lower. A drop...

Barchart

Fortune Brainstorm Health showcases health's dominant role in the U.S. economy

It seems every company is a now a health care company.

Fortune

California voters reject Proposition 29's mandates for kidney dialysis clinics

LOS ANGELES — For a third time, California voters rejected a statewide mandate to increase medical staffing at dialysis centers.

Los Angeles Times

California patients fear fallout from third dialysis ballot measure

ELK GROVE, Calif. — Toni Sherwin is actually looking forward to the procedure that will relocate her dialysis port from her chest to her arm, which will be easier to keep dry. Since she started dialysis in February — as part of blood cancer treatment — she has washed her…

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

As Prop. 29 vote looms, dialysis patients brace for change

LOS ANGELES — Socorro Reyes could feel himself getting sleepy as his blood pressure dropped.

Los Angeles Times

Calif.'s new dialysis ballot measure

SEIU says reforms are necessary to keep patients safe during the physically arduous dialysis process

Salon

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022

Upgrades

Benzinga

Michael Hiltzik: Obscenely rich dialysis firms are spending millions to defeat California's tighter regulations

A good rule of thumb for assessing the value of a business is to look at how much its owners will spend to defend it from regulations. By that measure, the dialysis business is very valuable indeed.

Los Angeles Times

Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022

Upgrades

Benzinga

Justice Kagan wrote "Now Congress will have to fix a statute this Court has broken."

And Congress is poised to fix the "loophole" left by the Supreme Court decision with a bill drafted by the Respondent.

Reason

$44 Million Bet On Occidental Petroleum? 3 Stocks Insiders are Buying

Although US stocks closed slightly lower on Monday, there were a few notable insider trades.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Roll Call

Supreme Court sides with insurer in dialysis coverage case - Roll Call

The Supreme Court decides in favor of an insurer in a case focused on reimbursement rates for kidney dialysis.

Benzinga

Medtronic, DaVita To Jointly Form Kidney Health-Focused Company

Medtronic plc (NYSE:MDT) and DaVita Inc (NYSE:DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney care products and solutions, including future home-based products. Medtronic and DaVita will co-own the NewCo, each with equal equity stakes and led by an…

Benzinga

DaVita's Return on Invested Capital Overview

Pulled from Benzinga Pro data, DaVita (NYSE:DVA) posted Q1 earnings of $205.72 million, an increase from Q4 of 17.53%. Sales dropped to $2.82 billion, a 4.28% decrease between quarters.

Investors Business Daily

These Are The Top 8 Stocks To Own In A Bear Market

The dreaded S&P 500 bear is nearly here. But don't think you need to hibernate to make money in a rough market.

Get all your
news in one place.

100’s of premium titles.
One news app.

Ballotpedia

The campaign behind California dialysis initiative files signatures for a place on the November ballot

Californians for Kidney Dialysis Patient Protection filed 692,521 raw signatures to place an initiative on the November ballot. The measure would enact staffing requirements, reporting requirements, ownership disclosure, and closing requirements for chronic dialysis clinics. The ballot initiative would also prohibit clinics from refusing to care for a patient based…

Benzinga

Recap: DaVita Q1 Earnings

DaVita (NYSE:DVA) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DaVita missed estimated earnings by 13.9%, reporting an EPS of $1.61 versus an estimate of $1.87.

Benzinga

DaVita: Q4 Earnings Insights

DaVita (NYSE:DVA) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DaVita beat estimated earnings by 12.22%, reporting an EPS of $2.02 versus an estimate of $1.8.

StockNews.com

3 Warren Buffett Stocks to Buy in February: DaVita, Bristol Myers Squibb, and AbbVie

Warren Buffett’s value investing strategy has paid off, as its investment firm Berkshire Hathaway (BRK.A) has outperformed the broader market. Recently, the billionaire has become worther than Meta Platforms (FB) founder Mark Zuckerberg. Hence, we believe that the Berkshire Hathaway holdings AbbVie (ABBV), Bristol-Myers Squibb (BMY), and DaVita (DVA) might…

1 2

People

[ Brett M. ] Kavanaugh

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.